CROI 2025: Tecovirimat has no benefit against mpox in STOMP study
18 March 2025. Related: Conference reports, mpox.
mpox
New mpox vaccination sites open in the UK
3 February 2025. Related: mpox.
Africa CDC special briefing on mpox and the impact of conflict
1 February 2025. Related: mpox.
Detailed results from PALM007 study: no clinical impact of tecovirimat against mpox clade 1
6 January 2025. Related: mpox.
Tecovirimat news continues: Japan approval includes mpox indication
2 January 2025. Related: mpox.
Tecovirimat fails to show benefit in randomised STOMP study in mpox clade 2
10 December 2024. Related: mpox, Other news.
Mpox breakthrough cases after two doses of the MVA-BN vaccine
1 November 2024. Related: mpox.
Confirmed mpox clade 1b case in Germany: risk remains low for EU/EEA
23 October 2024. Related: mpox.
Lack of tecovirimat activity against mpox clade 1
21 October 2024. Related: mpox, Coinfections and complications.
Efficacy of MVA-BN vaccine: systematic review
21 October 2024. Related: mpox.
Mpox outbreak in Australia: half of cases had previously received a vaccine
3 October 2024. Related: mpox.
WHO situation report on mpox
2 October 2024. Related: mpox.
UK orders 150,000 doses of MVA-BN mpox vaccine
16 September 2024. Related: mpox.
Responses to mpox clade 1b emergency: webinar details
1 September 2024. Related: mpox.
WHO declares new mpox emergency (clade 1b): tecovirimat not effective in DRC study
16 August 2024. Related: mpox.
New York continues mpox vaccine and health awareness campaign
5 May 2024. Related: mpox.
CROI 2024: Studies using tecovirimat to treat mpox
16 March 2024. Related: Conference reports, mpox.
Mpox updates: recent publications (2024)
2 February 2024. Related: mpox.
Clinical efficacy of tecovirimat for treatment of mpox in people living with HIV
10 January 2024. Related: mpox.
Mpox update: recent publications (2023)
1 December 2023. Related: mpox.
Mpox vaccines still available and recommended in the UK and US
1 December 2023. Related: mpox.
Tecovirimat resistance in a person with advanced HIV and delayed ART
1 September 2023. Related: mpox.
Early press conference: cure, gay circumcision, PrEP choices, mpox, and COVID-19
1 August 2023. Related: Conference reports, mpox, HIV prevention and transmission, Cure-related research, COVID-19: HIV and COVID-19 coinfection, COVID-19.
US studies report mpox vaccine efficacy from single- vs double-dose might only be 36% vs 66%
1 June 2023. Related: mpox.
UK data on efficacy of mpox vaccine: caution needed in observational analyses
6 April 2023. Related: mpox.
Updates on US mpox research: surveillance, testing, vaccines and research
6 April 2023. Related: mpox.
Cases of mpox reinfection in HIV negative men on PrEP: atovaquone, mefloquine and molnupiravir as potential treatments
6 April 2023. Related: mpox.
CROI 2023: Severe mpox outcomes with a low CD4 count and detectable viral load: a new AIDS-defining condition?
10 March 2023. Related: Conference reports, mpox.
Update on mpox: sleeping or hiding?
1 February 2023. Related: mpox.
Glasgow 2022: Mpox updates on epidemiology, treatment and prevention
1 December 2022. Related: Conference reports, mpox.
Monkeypox into Autumn: still no emergency funding, vaccine efficacy and UK declines further vaccines
3 October 2022. Related: Special reports, mpox.
Tecovirimat treatment for monkeypox in the UK: importance of the PLATINUM study
3 October 2022. Related: mpox.
Levels of monkeypox viral load in different body sites supports highest risk from body contact
3 October 2022. Related: mpox.
Severe complication of monkeypox reported to the US CDC: risks associated with HIV and other causes of immunosuppression
3 October 2022. Related: mpox.
New reports on MPX vaccine efficacy suggest protection but cases reported after two shots
3 October 2022. Related: mpox.
Other monkeypox studies of interest
3 October 2022. Related: mpox.
BHIVA, BASHH and other professional organisations publish open letters on the refusal by the UK government to acknowledge monkeypox crisis
3 October 2022. Related: mpox.
Update on monkeypox in the UK: reduced cases, vaccine access, transmission and treatment…
1 September 2022. Related: Special reports, mpox.
Montreal’s response to monkeypox: rapid vaccine rollout, 39 breakthrough infections
1 September 2022. Related: Conference reports, mpox.
Summary of 620 cases of monkeypox seen at three London clinics
1 September 2022. Related: Conference reports, mpox.
US survey reports 50% of gay men changed sexual behaviour to avoid monkeypox
1 September 2022. Related: mpox.
US model limits monkeypox infections by one-third from having fewer one-time partners: short-term strategy until next vaccine supply
1 September 2022. Related: mpox.
BHIVA include efficacy data on HIV and monkeypox vaccine: updated statement (August 2022)
1 September 2022. Related: mpox.
Monkeypox DNA detected in anal samples of asymptomatic men in Paris and Belgium
1 September 2022. Related: mpox.
Unusual case reports: non-sexual acquisition, severe MPX and advanced HIV, human-to-dog transmission
1 September 2022. Related: mpox.
Tecovirimat for treating mild monkeypox: new studies open in the UK and US
1 September 2022. Related: mpox.
US cases: MMWR report on 1891 cases to 22 July 2022
1 September 2022. Related: mpox.
Monkeypox transmission in heterosexual couples in Nigeria
1 September 2022. Related: mpox.
Access to vaccines and treatment for pregnant women at risk of monkeypox
1 September 2022. Related: mpox.
MPX DNA easily detected on surfaces in hospital after cleaning
1 September 2022. Related: mpox.
Understanding HIV and monkeypox coinfection: NEAT/EACS dashboard
1 September 2022. Related: mpox, Coinfections and complications.
BHIVA include efficacy data on HIV and monkeypox vaccine: updated statement
18 August 2022. Related: mpox, Coinfections and complications.
Taking a break from monkeypox: four weeks out for August
3 August 2022. Related: Special reports, mpox.
WHO declares the monkeypox pandemic a global health emergency
3 August 2022. Related: mpox, Coinfections and complications.
UK organisations call for £51 million to urgently tackle monkeypox crisis
3 August 2022. Related: mpox, Coinfections and complications.
EMA approves Imvanex vaccine against monkeypox in EU
3 August 2022. Related: mpox, Coinfections and complications.
International study of 528 monkeypox (MPX) cases: results from the 2022 outbreak need to inform new management guidelines
3 August 2022. Related: mpox, Coinfections and complications.
Tecovirimat to treatment monkeypox: an urgent need for both RCT and expanded access
3 August 2022. Related: mpox.
Monkeypox DNA detected at high levels in saliva and is common in semen and other samples
3 August 2022. Related: mpox, Coinfections and complications.
Risk of monkeypox being infectious on hard surfaces and soft materials: guidelines for effective cleaning
3 August 2022. Related: mpox, Coinfections and complications.
Outcomes of 54 cases of monkeypox (MPX) in London: fewer early symptoms but higher rates of genital lesions – urgency of funding sexual health
3 August 2022. Related: mpox, Coinfections and complications.
Ending the monkeypox outbreak through vaccination, contact tracing and early diagnosis
3 August 2022. Related: mpox, Coinfections and complications.
US doctors think it is already too late to contain monkeypox
3 August 2022. Related: mpox.
Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride
1 July 2022. Related: Special reports, mpox, Coinfections and complications.
UK offers limited vaccine to gay and bisexual men at risk of monkeypox: full dose offered in NYC
1 July 2022. Related: mpox, Coinfections and complications.